Furthermore, a recent proteomic analysis using a non-immune-based (liquid chromatography-tandem mass spectrometry) approach suggested that CNDP1 is one of several proteins down regulated in plasma of ten patients with glioblastoma compared with healthy controls [19]. This evidence concerns the gene CNDP1 and glioblastoma.